Sam Collins
Sam Collins (RSS)
InvestorPlace Chief Technical Analyst

Sam Collins is's Chief Technical Analyst. He has more than four decades of experience in Wall Street firms.

Read complete bio
Recent Articles

Tuesday’s Action Should Trigger a Tradable Rally

Oct. 15, 2014, 2:11 am EDT – Go for the long side, but use stop-loss orders. More 

The Best Undervalued Buys in the Market: Celgene (CELG)

Oct. 15, 2014, 1:44 am EDT – My list begins with a top biotech stock that could run more than 20%. More 

Investors Being Presented With an Unusual Buying Opportunity

Oct. 14, 2014, 2:43 am EDT – Those who wished for a correction to buy stocks at lower prices got what they asked for. More 

Protect the Fast Gains Made in Occidental Petroleum

Oct. 14, 2014, 1:45 am EDT – With the downside target in Occidental Petroleum (OXY) hit, it's time to place a trailing stop. More 

Shorter-Term Direction in Question, but Bull Market Remains Intact

Oct. 13, 2014, 2:16 am EDT – Last week's volatile trading could mark the beginning of a panic sell-off. More 

Don’t Let Your Gains in This Winner Evaporate

Oct. 13, 2014, 1:15 am EDT – Sanmina (SANM) has fallen 25% in the three weeks since my short sale recommendation. More 

Traders Should Take a Cautious Bullish Stance

Oct. 10, 2014, 2:31 am EDT – Sentiment is bearish and internal indicators are grossly oversold. More 

Put Amgen Back on Your Buy List

Oct. 10, 2014, 1:52 am EDT – The broad-based market correction has driven Amgen (AMGN) to just above its 50-day moving average. More 

Market Scores Key Reversal Day, but More Work to be Done

Oct. 9, 2014, 2:54 am EDT – A change in the near and intermediate downtrends has yet to be realized. More 

This Biotech’s Chart is the Picture of Health

Oct. 9, 2014, 1:06 am EDT – Gilead Sciences (GILD) consistently surpasses my technical targets. More